Global Radiotherapy Market Industry Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global radiotherapy market covers the hardware, software, and services used to deliver ionizing radiation to treat cancer patients, including external beam radiation therapy, brachytherapy, and systemic radiotherapy solutions. Market estimates for 2025 vary across private research firms, ranging from roughly $6 billion to $8.7 billion, reflecting differences in scope and methodology. No official government statistical agency publishes a dedicated market size figure for this industry.

• •2025 global market estimates range from $6.05 billion to $8.73 billion depending on research firm scope
• •No government statistical agency publishes dedicated radiotherapy market valuation figures
• •Market includes external beam radiotherapy, brachytherapy, and related software and services

Rising global cancer incidence is the primary demand driver, with radiotherapy remaining a cornerstone of cancer treatment alongside surgery and chemotherapy. An aging global population increases cancer risk, while technological advances, such as intensity-modulated radiotherapy, stereotactic body radiation therapy, and proton therapy, improve treatment precision and expand clinical indications. Expanding healthcare infrastructure in emerging markets and growing insurance coverage for advanced radiotherapy also support market expansion.

• •Increasing global cancer prevalence drives demand for radiotherapy as a core treatment modality
• •Technological advances in precision radiation delivery broaden treatable indications and adoption
• •Aging populations and improving healthcare access in emerging markets fuel long-term growth

The market is typically segmented by product type, including external beam radiotherapy systems, brachytherapy devices, and radiotherapy software, and by end user such as hospitals, specialty clinics, and cancer research institutes. North America and Europe currently account for the largest revenue share due to advanced healthcare infrastructure, high adoption of cutting-edge radiotherapy technologies, and favorable reimbursement frameworks. The Asia-Pacific region is the fastest-growing segment, driven by rising cancer rates, improving healthcare access, and government investments in cancer care infrastructure.

• •North America and Europe lead in revenue share due to established healthcare infrastructure and technology adoption
• •Asia-Pacific is the fastest-growing region, fueled by rising cancer prevalence and expanding treatment access
• •Product segments include external beam radiotherapy systems, brachytherapy devices, and treatment planning software

What are the recent trends and outlook?

Key emerging trends include the integration of artificial intelligence into treatment planning and imaging, the adoption of hybrid treatment suites combining imaging and therapy, and increasing interest in proton and heavy-ion therapy for precision treatment. The shift toward value-based healthcare is encouraging innovations that improve treatment outcomes while reducing side effects and overall treatment costs. Over the forecast period, the market is expected to continue expanding as radiotherapy technologies become more accessible, more precise, and more broadly adopted across both developed and developing healthcare systems.

• •Artificial intelligence is increasingly integrated into radiotherapy treatment planning and tumor targeting
• •Proton and particle therapy are gaining traction for their ability to deliver high-dose radiation with minimal damage to surrounding tissue
• •Hybrid treatment suites combining imaging and radiotherapy are driving next-generation treatment workflows